Back to User profile » Dr David Gelmont
Paper published by Dr David Gelmont:
Original Research
Safety and tolerability of an intravenously administered alpha1-proteinase inhibitor at an increased infusion rate: a novel, randomized, placebo-masked, infusion rate-controlled, crossover study in healthy adults
Ngo LY, Haeberle A, Dyck-Jones J, Gelmont D, Yel L
Open Access Journal of Clinical Trials 2014, 6:55-61
Published Date: 23 June 2014